China Yct International Group (CYIG) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket
 


China Yct International Group, Inc.  (CYIG)


China Yct International Group's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is China Yct International Group's ROA in the third quarter of 2019?
China Yct International Group, Inc. achieved a return on average assets (ROA) of 14.41 % in its third quarter of 2019, this is above CYIG's average return on assets of 13.86%.
China Yct International Group, Inc. assets over the 12 months ending in its third quarter of 2019 are valued at $111 million

ROA has improved compared to 13.3% in the second quarter of 2019, due to net income growth.

However, within the Healthcare sector 55 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2018 quarter, so far to 527, from total ROA ranking in the second quarter of 2019 at 548.

What is ROA?



Return On Assets (Dec 31 2018)
III. Quarter
(Sep 30 2018)
II. Quarter
(Jun 30 2018)
I. Quarter
(Mar 31 2018)
IV. Quarter
(Dec 31 2017)
III. Quarter
Y / Y Total Assets Change 11.1 % 11.27 % 15.28 % 20.78 % 24.78 %
Y / Y Net Income Change 56.37 % 82.42 % 17.8 % -32.15 % 10.59 %
Net Income (TTM) in million 16 14 12 12 13
Return On Assets (TTM) 14.41 % 13.3 % 11.84 % 11.57 % 13.43 %
CYIG's Total Ranking # 527 # 548 # 456 # 407 # 378
Total Assets (TTM) in million 114 110 109 110 103
Seq. Total Assets Change 4.32 % 0.75 % -1.27 % 7.05 % 4.48 %
Seq. Net Income Change 6.41 % -9.1 % 75.05 % -7.66 % 24.14 %



Return On Assets Company Ranking
Within: No.
Industry # 26
Sector # 56
Overall # 362

Return On Assets Statistics
High Average Low
85.06 %
13.86 %
-42.88 %
(Mar 31 2013)   (Jun 30 2012)





Financial Statements
China Yct International Group's Assets $ 114 million CYIG's Balance sheet
China Yct International Group's Income $ 4 million Quarterly CYIG's Income Statement
CYIG's Income by Division See CYIG's Income by Division



Annual Return On Assets (Mar 31 2018)
FY 2018
(Mar 31 2017)
FY 2017
(Mar 31 2016)
FY 2016
(Mar 31 2015)
FY 2015
(Mar 31 2014)
FY 2014
Y / Y Total Assets Change 21.99 % 11.03 % 5.39 % 14.78 % 14.58 %
Total Assets in million 110 90 81 77 67
Y / Y Net Income Change 16.75 % 19.46 % -5.33 % 9.48 % -0 %
Net Income in million 12 10 8 9 8
Annual Return On Assets 10.66 % 11.14 % 10.35 % 11.52 % 12.08 %




Comment on CYIG's ROA in the fiscal year ending 2018
In the fiscal year 2018 ROA deteriorated to 10.66 %, despite annual net income growth of 16.75 % to $11.74 million, from $10.05 million a year ago, as CYIG's assets increase to $110.14 million, by 16.75 %.


More Return On Assets Ratios
CYIG's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYIG's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYIG's Competitors
Subscribers only: Roa for China Yct International Group's Suppliers
Subscribers only: Return On Assets for CYIG's Customers

You may also want to know
CYIG's Roi CYIG's Inventory Turnover Ratio CYIG's Growth Rates CYIG's Dividend Comparisons
CYIG's Profitability Ratios CYIG's Asset Turnover Ratio CYIG's Dividend Growth
CYIG's Roe CYIG's Valuation Ratios CYIG's Financial Strength Ratios CYIG's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2018, within Healthcare Sector ROA
Purple Biotech Ltd  37.83 %
Nektar Therapeutics  37.80 %
Novo Nordisk A  36.04 %
Oramed Pharmaceuticals Inc  34.58 %
Cv Sciences Inc   33.89 %
Orgenesis Inc   32.63 %
Corcept Therapeutics Inc  26.72 %
Nrc Health  26.67 %
Molecular Templates Inc   26.41 %
Abiomed Inc   25.78 %
Idexx Laboratories Inc  24.84 %
Alpha Pro Tech Ltd   23.66 %
Regeneron Pharmaceuticals Inc   23.36 %
Regenxbio Inc   23.35 %
Biospecifics Technologies Corp  22.31 %
Enanta Pharmaceuticals Inc  22.09 %
Fonar Corporation  21.68 %
Chemed Corporation  21.66 %
Align Technology inc   20.85 %
Fuse Medical Inc   20.60 %
Strongbridge Biopharma plc  20.19 %
Mettler toledo International Inc   20.01 %
Utah Medical Products Inc  18.88 %
Masimo Corp  18.40 %
United Therapeutics Corporation  18.02 %
Biogen Inc   17.75 %
Psychemedics Corporation  17.28 %
Tivity Health Inc   16.77 %
Pacific Health Care Organization Inc  16.77 %
Lemaitre Vascular Inc   16.27 %


Date modified: 2026-09-08T15:09:21+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.